Arcus Capital Partners LLC Decreases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Arcus Capital Partners LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,373 shares of the healthcare conglomerate’s stock after selling 165 shares during the period. Arcus Capital Partners LLC’s holdings in UnitedHealth Group were worth $679,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Friedenthal Financial bought a new position in UnitedHealth Group during the 3rd quarter valued at about $51,000. DecisionPoint Financial LLC lifted its stake in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Finally, Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $55,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $531.31 on Friday. The firm’s fifty day simple moving average is $524.58 and its two-hundred day simple moving average is $563.71. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market capitalization of $488.96 billion, a P/E ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $629.32.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.